241 related articles for article (PubMed ID: 34927740)
1. Comparison of transperineal and transrectal targeted prostate biopsy using Mahalanobis distance matching within propensity score caliper method: A multicenter study of Turkish Urooncology Association.
Koparal MY; Sözen TS; Karşıyakalı N; Aslan G; Akdoğan B; Şahin B; Türkeri L;
Prostate; 2022 Mar; 82(4):425-432. PubMed ID: 34927740
[TBL] [Abstract][Full Text] [Related]
2. Transperineal Versus Transrectal MRI/TRUS Fusion Targeted Biopsy: Detection Rate of Clinically Significant Prostate Cancer.
Pepe P; Garufi A; Priolo G; Pennisi M
Clin Genitourin Cancer; 2017 Feb; 15(1):e33-e36. PubMed ID: 27530436
[TBL] [Abstract][Full Text] [Related]
3. The eternal enigma in prostatic biopsy access route.
Fabiani A; Principi E; Filosa A; Servi L
Arch Ital Urol Androl; 2017 Oct; 89(3):245-246. PubMed ID: 28969413
[TBL] [Abstract][Full Text] [Related]
4. Do cancer detection rates differ between transperineal and transrectal micro-ultrasound mpMRI-fusion-targeted prostate biopsies? A propensity score-matched study.
Rakauskas A; Peters M; Martel P; van Rossum PSN; La Rosa S; Meuwly JY; Roth B; Valerio M
PLoS One; 2023; 18(1):e0280262. PubMed ID: 36652429
[TBL] [Abstract][Full Text] [Related]
5. Detection of Clinically Significant Prostate Cancer Using Targeted Biopsy with Four Cores Versus Target Saturation Biopsy with Nine Cores in Transperineal Prostate Fusion Biopsy: A Prospective Randomized Trial.
Saner YM; Wiesenfarth M; Weru V; Ladyzhensky B; Tschirdewahn S; Püllen L; Bonekamp D; Reis H; Krafft U; Heß J; Kesch C; Darr C; Forsting M; Wetter A; Umutlu L; Haubold J; Hadaschik B; Radtke JP
Eur Urol Oncol; 2023 Feb; 6(1):49-55. PubMed ID: 36175281
[TBL] [Abstract][Full Text] [Related]
6. Surface-projection-based transperineal cognitive fusion targeted biopsy of the prostate: an original technique with a good cancer detection rate.
Wang L; Wang X; Zhao W; Zhao Z; Li Z; Fei S; Zhu H; Ji X; Yang B; Li N; Na Y
BMC Urol; 2019 Nov; 19(1):107. PubMed ID: 31684917
[TBL] [Abstract][Full Text] [Related]
7. Should Targeted Biopsy be Performed in Patients Who Have Only Pi-rads 3 Lesions?
Koparal MY; Sözen TS; Karşiyakali N; Akdoğan B; Özen H; Aslan G; Türkeri L
Arch Esp Urol; 2022 Jun; 75(5):410-415. PubMed ID: 35983811
[TBL] [Abstract][Full Text] [Related]
8. Critical evaluation of magnetic resonance imaging targeted, transrectal ultrasound guided transperineal fusion biopsy for detection of prostate cancer.
Kuru TH; Roethke MC; Seidenader J; Simpfendörfer T; Boxler S; Alammar K; Rieker P; Popeneciu VI; Roth W; Pahernik S; Schlemmer HP; Hohenfellner M; Hadaschik BA
J Urol; 2013 Oct; 190(4):1380-6. PubMed ID: 23608676
[TBL] [Abstract][Full Text] [Related]
9. Transperineal Versus Transrectal Targeted Biopsy With Use of Electromagnetically-tracked MR/US Fusion Guidance Platform for the Detection of Clinically Significant Prostate Cancer.
; ; . PubMed ID: 32956688
[No Abstract] [Full Text] [Related]
10.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
11.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
12.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
13.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
14.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
15.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
16.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
17.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
18.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]